Global Glycated Albumin market is growing at a CAGR of 4.9% during 2018-2025
The glycated albumin market is predicted to rise at an impressive close to 6% CAGR between 2019 and 2024 vis-à-vis revenue. Firstly, usefulness and efficacy of glycated albumin assay for diabetes monitoring is serving to boost the glycated albumin market. Further, high reliability of glycated albumin as a glycemic indicator over glycated hemoglobin further benefits the glycated albumin market.
Get PDF Sample for Detailed Analysis of this Research @ https://www.researchmoz.us/enquiry.php?type=S&repid=1915496
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.
Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose present in diabetes meatus results in increased glycation of all proteins, including, albumin. Measurement of the amount of the glycation reaction resulting from the combination of glucose with free amino groups in proteins present in the blood is used to monitor the level of glucose that has generally been present in body fluids over a preceding period.
Thus serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the gycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.
Glycated albumin industry is relatively concentrated, manufacturers are mostly in the Europe, North America, Japan and China. Among them, Japan output value accounted for more than 81.90% of the total output value of global glycated albumin. Asahi Kasei Pharma is the world leading manufacturer in global glycated albumin market with the market share of 79.81% in 2015, in terms of revenue.
There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality.
The average price of glycated albumin will fall further. The product average price declined in the past few years due to the technology development, the average price will keep this trend in the few future years due to increasing mature manufacturing technology and cost of raw materials.
The global Glycated Albumin market is valued at 340 million US$ in 2017 and will reach 500 million US$ by the end of 2025, growing at a CAGR of 4.9% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Glycated Albumin market based on company, product type, end user and key regions.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Asahi Kasei Pharma
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1915496
Market size by Product
Glycated Albumin (Human)
Glycated Albumin (Animal)
Market size by End User
Hospitals and Clinics
Market size by Region
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
Mr. Nachiket Ghumare,
USA-Canada Toll Free: 866-997-4948
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Glycated Albumin market is growing at a CAGR of 4.9% during 2018-2025 here
News-ID: 1729108 • Views: 436
More Releases from Glycated Albumin Market
Glycated Albumin Market Report 2018 Companies included Asahi Kasei Pharma, DIAZY …
We have recently published this report and it is available for immediate purchase. For inquiry Email us on: firstname.lastname@example.org ********* This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides
Glycated Albumin Market Report for Period 2018 till 2024 Asahi Kasei Pharma, DIA …
Global Glycated Albumin market report emphasizes on detailed analysis of companies and manufacturers like BSBE, Medicalsystem, Maccura, Leadman, Simes Sikma, NINGBO PUREBIO, Asahi Kasei Pharma, DIAZYME, Abnova, LifeSpan, Exocell and Others. This market study includes data about global market statistics, market share, company performances, historical analysis 2012 to 2016, market forecast 2017 to 2023 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2017 to 2023,
Glycated Albumin Market Overview and Forecast Report 2017 to 2022
eMarketOrg.com adds “Global Glycated Albumin Market Research Report 2017” new report to its research database. The report spread across 115 pages with table and figures in it. For this report, the Glycated Albumin market value is provided for 2016 in USD millions, an expected CAGR % as well as USD million worth of industry in 2022. Regionally, the globe is segmented into United States, China, Europe, Japan, Southeast Asia and India